1. India Stocks

  2. •

    Financial Services

  3. •

    Investment - Banking & Investment Services
Biogen Pharmachem Industries L

Biogen Pharmachem Industries L

BIOGEN.BO
Biogen Pharmachem Industries LIN flagBombay Stock Exchange
0.31
INR
+0.01
- -
279.81MMarket Cap
Biogen Pharmachem Industries L
BIOGEN.BO
(Bombay Stock Exchange)

Recent

price

0.31

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
- -
28.02
- -
- -
- -
- -
- -
-0.09
0.01
- -
- -
0.03
0.01
- -
- -
- -
- -
Revenue per Share
-0.01
-0.01
-0.01
-0.01
-0.01
- -
- -
-0.09
- -
- -
-0.02
- -
0.01
0.03
- -
- -
0.01
Basic EPS, GAAP
-0.48
-0.8
1.85
- -
-0.61
0.39
- -
-0.18
- -
-0.02
0.05
0.02
0.02
0.03
-0.01
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
5.14
5.13
5.45
5.11
5.1
5.09
0.8
0.71
0.71
0.73
0.71
0.71
0.72
0.74
0.86
- -
0.86
Book Value per Share
5.14
5.13
5.12
5.11
5.1
5.09
0.8
0.71
0.71
0.73
0.71
0.71
0.72
0.74
1.21
- -
0.94
Tangible Book Value per Share
120
120
120
120
120
120
761
761
761
761
761
761
761
761
761
- -
1,053
Basic Weighted Avg Shares
- -
3,354
- -
- -
- -
- -
- -
-66
9
- -
- -
22
7
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
-0.03
- -
- -
- -
- -
450.06
100.79
-0.37
46,678.72
-11,079.84
-0.52
31.32
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-2
-1
-1
-1
-1
- -
-1
-66
- -
-1
-16
- -
5
19
-3
10
10
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-0.03
- -
- -
- -
- -
452.94
99.06
-0.37
46,678.72
-11,080.17
-0.4
68.41
- -
- -
- -
- -
Profit Margin (%)
266
209
440
-135
254
142
- -
70
69
80
25
11
-1
-2
26
3
3
Working Capital
- -
- -
- -
- -
77
62
7
- -
6
3
- -
- -
- -
- -
- -
- -
- -
LT Debt
615
614
613
611
610
610
608
543
543
557
541
541
546
565
919
991
991
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.38
3.48
- -
1
0.54
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.84
3.48
- -
1.23
1.31
Return on Capital (%)
-0.43
-0.15
-0.21
-0.21
-0.22
-0.05
-0.2
-11.4
-0.01
-0.21
-2.92
-0.02
0.84
3.48
-0.48
1.23
1.31
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,053
- -
1,053
Market Capitalization
632
569
537

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
23
- -
5
Cash, Cash Equivalents & STI
4
- -
5
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
- -
2
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.36%
14.96%
7.79%
Free Cash Flow
1,781.13%
-85.69%
-243.75%
Net Income, GAAP
430.92%
-1,142.82%
-426.85%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
8
- -
- -
16
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
- -
- -
0.03
2025
- -
-0.02
- -
0.02
- -
2026
0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Comfort Commotrade Limited (COMCL.BO)
WhiteHorse Finance, Inc. 7.875% Notes due 2028 (WHFCL)
Sai Capital Ltd. (SAICAPI.BO)
Purshottam Investofin Ltd (PURSHOTTAM.BO)
Epic Corp 5 % Conv Pfd Shs Series A (EPORP)
Alna Trading & Exports Ltd. (ALNATRD.BO)
Business
Biogen Pharmachem Industries Ltd (BIOGEN.BO) operates as a financial services company primarily engaged in the trading of shares and securities in present and future markets, including commodities trading in agro-based products and precious metals; it also provides stock broking and consulting services while diversifying into the power sector through wind power generation. Incorporated in 1995 and headquartered in Rajkot, Gujarat, India, at Shop No. 8, First Floor, Makers-1 Building, Jawahar Road, the company serves domestic markets with a focus on equity and derivative instruments. It was formerly known as Sun Techno Overseas Ltd, with a name change to Biogen Pharmachem Industries Ltd in March 2021, marking a significant rebranding and operational shift from its earlier identity as Wellworth Overseas Ltd in 2011. In recent developments, the company reported standalone net sales of Rs 1.54 crore in the June 2025 quarter, up substantially year-over-year, alongside a board meeting in July 2025 to consider strategic matters and receipt of INR 105 million in funding from Interface Financial Services Limited and Parichay, supporting its ongoing financial activities amid quarterly net losses.